OP0001 Hypothyroidism as a potential biomarker of efficacy of famitinib, a novel VEGFR2 inhibitor in metastatic breast cancer

✍ Scribed by Cao, J.; Zhang, J.; Wang, Z.H.; Wang, B.Y.; Lv, F.F.; Wang, L.P.; Hu, X.C.

• Book ID: 125820368
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 222 KB
• Volume: 50
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/j.ejca.2014.03.019